Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The AstraZeneca Intelligent Healthcare Innovation Center (ITIC), located in Wuxi, China, is a collaborative platform established by AstraZeneca in partnership with the Wuxi municipal government. Launched in 2017, the center serves as an incubator and innovation hub for digital health, artificial intelligence, and Internet of Things (IoT) solutions within the healthcare sector. It focuses on developing integrated disease management solutions across multiple therapeutic areas, including oncology, cardiovascular, renal, metabolic, and respiratory diseases. By fostering collaborations between technology giants, startups, and healthcare providers, ITIC aims to transform the patient journey through data-driven insights and smart medical technologies. The center operates several specialized innovation sub-centers dedicated to specific disease areas to accelerate the commercialization of novel healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intelligent Technology Innovation Center.